Related Experiment Video
Updated: Mar 12, 2026

07:35
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
Published on: October 13, 2023
2.3K
Deciphering lncRNA-disease associations based on multi-representation fusion and boosting with Gaussian process
IEEE Journal of Biomedical and Health Informatics
|March 10, 2026
Summary
This study introduces LDA-RMGPB, a novel deep learning framework for identifying long noncoding RNA-disease associations (LDAs). LDA-RMGPB effectively fuses lncRNA and disease features, outperforming existing methods in predicting unknown lncRNA-disease pairs for disease pathogenesis insights.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Long noncoding RNA-disease association (LDA) identification is crucial for understanding disease pathogenesis.
- Current deep learning models struggle with effective feature fusion and accurate classification of unknown lncRNA-disease pairs (LDPs).
Purpose of the Study:
- To develop a novel deep learning framework, LDA-RMGPB, for enhanced LDA prediction.
- To improve the fusion of multi-representation features for lncRNAs and diseases.
- To accurately classify unknown LDPs.
Main Methods:
- Utilized randomized singular value decomposition for extracting linear LDP features.
- Employed a masked graph autoencoder to learn nonlinear LDP features.
- Applied a boosting algorithm with Gaussian process for classifying unlabeled LDPs using fused features.
Main Results:
- LDA-RMGPB significantly outperformed seven state-of-the-art methods across six evaluation metrics and four cross-validation strategies on two LDA datasets.
- Further analyses confirmed LDA-RMGPB's superior LDA identification capabilities.
- Predicted potential LDA linkages for lncRNAs ATP6V1G2-DDX39B and PSORS1C3 with breast cancer and prostatic neoplasms, respectively.
Conclusions:
- LDA-RMGPB offers a robust approach for identifying lncRNA-disease associations, contributing to disease mechanism understanding.
- The framework facilitates the discovery of novel therapeutic molecular targets.
- LDA-RMGPB is publicly available for research use.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
16.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.4K
lncRNA - Long Non-coding RNAs
3.8K
3.8K
lncRNA - Long Non-coding RNAs
10.1K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
RNA-seq
12.3K
RNA sequencing, or RNA-Seq, is a high-throughput sequencing technology used to study the transcriptome of a cell. Transcriptomics helps to interpret the functional elements of a genome and identify the molecular constituents of an organism. Additionally, it also helps in understanding the development of an organism and the occurrence of diseases.
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
12.3K

